Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: Preliminary clinical evidence

Psychopharmacology

Volumn 154, Issue 1, 2001, Pages 23-27

  Ait Daoud, N ^a   Johnson, B A ^a   Prihoda, T J ^a   Hargita, I D ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

5 HT3 antagonist; Alcoholism; Craving; Human; Naltrexone; Obsessive compulsive drinking scale; Ondansetron; Opioid antagonist; Serotonin (5 HT); Subtype; Treatment

Indexed keywords

NALTREXONE; ONDANSETRON; RECEPTOR SUBTYPE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; GENETIC PREDISPOSITION; HUMAN; MALE; ONSET AGE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; WITHDRAWAL SYNDROME;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; COGNITIVE THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; ONDANSETRON; SEROTONIN ANTAGONISTS;

EID: 0035117372     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000607     Document Type: Article

References (26)

1. The obsessive compulsive drinking scale
2. Types of alcoholics: Concurrent and predictive validity of some common classifications schemes
3. The motivation to use drugs: A psychobiological analysis of urges
4. Psychometric properties and validity of the obsessive-compulsive drinking scale
5. The effects of combinations of intranasal cocaine, smoked marijuana, and task performance on heart rate and blood pressure
6. Cocaine self-administration research: Treatment implications
7. Implication of the endogenous opioid system in excessive ethanol consumption
8. 3 receptor blockade: A preliminary study in healthy male volunteers
9. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients
10. Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population
11. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: From hypotheses to preliminary clinical evidence
12. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence
13. 3 receptor antagonists in the regulation of alcohol intake
14. 3 and opioid receptors in the ethanol-induced place preference in rats exposed to conditioned fear stress
15. Naltrexone's effect on cue-elicited craving among alcoholics in treatment
16. Influence of naltrexone on cue-elicited craving among hazardous drinkers: The moderational role of positive outcome expectancies
17. Measurement of drug craving during naloxone-precipitated withdrawal in methadone-maintained volunteers
18. Timeline follow-back: A technique for assessing self-reported alcohol consumption
19. Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment of alcohol scale (CIWA-Ar)
20. The development of a cocaine craving questionnaire